Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Brain Neoplasms"" wg kryterium: Temat


Tytuł :
Radiation necrosis in renal cell carcinoma brain metastases treated with checkpoint inhibitors and radiosurgery: An international multicenter study.
Autorzy :
Lehrer EJ; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.
Gurewitz J; Department of Radiation Oncology, NYU Langone Medical Center, New York, New York.
Bernstein K; Department of Radiation Oncology, NYU Langone Medical Center, New York, New York.
Patel D; Department of Neurosurgery, NYU Langone Medical Center, New York, New York.
Kondziolka D; Department of Neurosurgery, NYU Langone Medical Center, New York, New York.
Niranjan A; Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Wei Z; Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Lunsford LD; Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Malouff TD; Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida.
Ruiz-Garcia H; Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida.
Patel S; Division of Radiation Oncology, Department of Oncology, University of Alberta, Edmonton, Alberta, Canada.
Bonney PA; Department of Neurosurgery, University of Southern California, Los Angeles, California.
Hwang L; Department of Radiation Oncology, University of Southern California, Los Angeles, California.
Yu C; Department of Neurosurgery, University of Southern California, Los Angeles, California.
Zada G; Department of Neurosurgery, University of Southern California, Los Angeles, California.
Mathieu D; Department of Neurosurgery, Université de Sherbrooke, Centre de Recherche du CHUS, Quebec, Quebec, Canada.
Trudel C; Department of Medicine, Université de Sherbrooke, Centre de Recherche du CHUS, Quebec, Quebec, Canada.
Prasad RN; Department of Radiation Oncology, Ohio State University Wexner Medical Center, Columbus, Ohio.
Palmer JD; Department of Radiation Oncology, Ohio State University Wexner Medical Center, Columbus, Ohio.
Jones BM; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.
Sharma S; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.
Fakhoury KR; Department of Radiation Oncology, University of Colorado, Denver, Colorado.
Rusthoven CG; Department of Radiation Oncology, University of Colorado, Denver, Colorado.
Deibert CP; Department of Neurological Surgery, Emory University, Atlanta, Georgia.
Picozzi P; Department of Neurosurgery, Humanitas Research Hospital-IRCCS, Rozzano, Italy.
Franzini A; Department of Neurosurgery, Humanitas Research Hospital-IRCCS, Rozzano, Italy.
Attuati L; Department of Neurosurgery, Humanitas Research Hospital-IRCCS, Rozzano, Italy.
Lee CC; Department of Neurosurgery, Neurological Institute, Taipei Veteran General Hospital, Taipei, Taiwan.
Yang HC; Department of Neurosurgery, Neurological Institute, Taipei Veteran General Hospital, Taipei, Taiwan.
Ahluwalia MS; Department of Medical Oncology, Miami Cancer Institute, Miami, Florida.
Sheehan JP; Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia.
Trifiletti DM; Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida.
Pokaż więcej
Źródło :
Cancer [Cancer] 2022 Apr 01; Vol. 128 (7), pp. 1429-1438. Date of Electronic Publication: 2022 Jan 25.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Brain Neoplasms*/radiotherapy
Brain Neoplasms*/secondary
Carcinoma, Renal Cell*/radiotherapy
Kidney Neoplasms*/etiology
Kidney Neoplasms*/radiotherapy
Radiosurgery*/adverse effects
Aged ; Cranial Irradiation ; Humans ; Necrosis/etiology ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Pretreatment patient-reported cognitive function in patients with diffuse glioma.
Autorzy :
Schei S; Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway. .; Department of Neurology, St. Olavs hospital, Trondheim, Norway. .
Solheim O; Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Neurosurgery, St. Olavs hospital, Trondheim, Norway.
Salvesen Ø; Unit for Applied Clinical Research, Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Hjermstad MJ; Regional Advisory Unit in Palliative Care, Department of Oncology, Oslo University Hospital, Oslo, Norway.; European Palliative Care Research Centre, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Bouget D; Department of Health Research, SINTEF Digital, Trondheim, Norway.
Sagberg LM; Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Neurosurgery, St. Olavs hospital, Trondheim, Norway.
Pokaż więcej
Źródło :
Acta neurochirurgica [Acta Neurochir (Wien)] 2022 Mar; Vol. 164 (3), pp. 703-711. Date of Electronic Publication: 2022 Feb 10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Brain Neoplasms*/complications
Brain Neoplasms*/psychology
Brain Neoplasms*/surgery
Cognitive Dysfunction*/complications
Cognitive Dysfunction*/etiology
Glioma*/complications
Glioma*/epidemiology
Glioma*/surgery
Cognition ; Humans ; Patient Reported Outcome Measures ; Quality of Life
Czasopismo naukowe
Tytuł :
ITGB2 as a prognostic indicator and a predictive marker for immunotherapy in gliomas.
Autorzy :
Xu H; Department of Neurosurgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.; Department of Neurosurgery, School of Medicine, Second Affiliated Hospital, Zhejiang University, Zhejiang, China.
Zhang A; Department of Neurosurgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.; Department of Neurosurgery, School of Medicine, Second Affiliated Hospital, Zhejiang University, Zhejiang, China.
Han X; Department of Orthopedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 650 New Songjiang Road, Shanghai, 200080, China.
Li Y; Department of Laboratory Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhang Z; Department of Neurosurgery, School of Medicine, Second Affiliated Hospital, Zhejiang University, Zhejiang, China.
Song L; Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
Wang W; Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, 030001, Shanxi, China. .
Lou M; Department of Neurosurgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China. .
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2022 Mar; Vol. 71 (3), pp. 645-660. Date of Electronic Publication: 2021 Jul 27.
Typ publikacji :
Journal Article
MeSH Terms :
Biomarkers, Tumor*
Brain Neoplasms/*metabolism
Brain Neoplasms/*mortality
Glioma/*diagnosis
Glioma/*metabolism
Integrin beta1/*metabolism
Brain Neoplasms/etiology ; Brain Neoplasms/therapy ; Computational Biology/methods ; Databases, Genetic ; Disease Progression ; Gene Expression Profiling ; Glioma/mortality ; Glioma/therapy ; Humans ; Integrin beta1/genetics ; Lymphocytes, Tumor-Infiltrating/immunology ; Lymphocytes, Tumor-Infiltrating/metabolism ; Neoplasm Grading ; Neoplasm Metastasis ; Neoplasm Staging ; Prognosis ; Proportional Hazards Models ; Transcriptome ; Tumor Microenvironment/genetics ; Tumor Microenvironment/immunology ; Tumor-Associated Macrophages/immunology ; Tumor-Associated Macrophages/metabolism
Czasopismo naukowe
Tytuł :
The prognostic significance of further genotyping H3G34 diffuse hemispheric gliomas.
Autorzy :
Vuong HG; Department of Neurosurgery, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma.
Le HT; Department of Pathology, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
Dunn IF; Department of Neurosurgery, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma.
Pokaż więcej
Źródło :
Cancer [Cancer] 2022 May 15; Vol. 128 (10), pp. 1907-1912. Date of Electronic Publication: 2022 Feb 23.
Typ publikacji :
Journal Article; Review; Systematic Review
MeSH Terms :
Brain Neoplasms*/genetics
Brain Neoplasms*/pathology
Glioma*/pathology
Genotype ; Glycine/genetics ; Humans ; Prognosis
Czasopismo naukowe
Tytuł :
Genomic analysis of paired IDHwt glioblastomas reveals recurrent alterations of MPDZ at relapse after radiotherapy and chemotherapy.
Autorzy :
Chanez B; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France; APHM, CHU Timone, Service de Neurooncologie, Marseille, France.
Appay R; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France; APHM, Timone Hospital, Department of Anatomopathology, 13005 Marseille, France.
Guille A; Centre de Recherche en Cancérologie de Marseille, INSERM UMR1068, Institut Paoli-Calmettes, Predictive Oncology Team, France.
Lagarde A; APHM, Hôpital de la Conception, Service de Biologie Moléculaire, 13005 Marseille, France.
Colin C; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
Adelaide J; Centre de Recherche en Cancérologie de Marseille, INSERM UMR1068, Institut Paoli-Calmettes, Predictive Oncology Team, France.
Denicolai E; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France; Centre de Recherche en Cancérologie de Marseille, INSERM UMR1068, Institut Paoli-Calmettes, Predictive Oncology Team, France.
Jiguet-Jiglaire C; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
Bequet C; APHM, CHU Timone, Service de Neurooncologie, Marseille, France.
Graillon T; APHM, Timone Hospital, Department of Neuro-Surgery, 13005 Marseille, France.
Boissonneau S; APHM, Timone Hospital, Department of Neuro-Surgery, 13005 Marseille, France.
Nanni-Metellus I; APHM, North Hospital, Transfert Laboratory, 13015 Marseille, France.
Dufour H; APHM, Timone Hospital, Department of Neuro-Surgery, 13005 Marseille, France.
Figarella-Branger D; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France; APHM, Timone Hospital, Department of Anatomopathology, 13005 Marseille, France.
Chinot O; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France; APHM, CHU Timone, Service de Neurooncologie, Marseille, France.
Tabouret E; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France; APHM, CHU Timone, Service de Neurooncologie, Marseille, France. Electronic address: .
Pokaż więcej
Źródło :
Journal of the neurological sciences [J Neurol Sci] 2022 May 15; Vol. 436, pp. 120207. Date of Electronic Publication: 2022 Feb 24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Brain Neoplasms*/drug therapy
Brain Neoplasms*/genetics
Brain Neoplasms*/radiotherapy
Glioblastoma*/drug therapy
Glioblastoma*/genetics
Glioblastoma*/radiotherapy
Glioma*/genetics
Humans ; Membrane Proteins ; Middle Aged ; RNA, Messenger ; Recurrence
Czasopismo naukowe
Tytuł :
A comprehensive bioinformatic analysis of cyclin-dependent kinase 2 (CDK2) in glioma.
Autorzy :
Liu H; Biocomma Limited, Shenzhen, China. Electronic address: .
Weng J; Department of Pathology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, Guangdong, China. Electronic address: .
Pokaż więcej
Źródło :
Gene [Gene] 2022 May 15; Vol. 822, pp. 146325. Date of Electronic Publication: 2022 Feb 17.
Typ publikacji :
Journal Article
MeSH Terms :
Up-Regulation*
Brain Neoplasms/*pathology
Computational Biology/*methods
Cyclin-Dependent Kinase 2/*genetics
Glioma/*pathology
Adult ; Aged ; B-Lymphocytes/metabolism ; Brain Neoplasms/genetics ; Brain Neoplasms/immunology ; CD4-Positive T-Lymphocytes/metabolism ; CD8-Positive T-Lymphocytes/metabolism ; Case-Control Studies ; Databases, Genetic ; Female ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Glioma/genetics ; Glioma/immunology ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; Nomograms ; Prognosis ; Survival Analysis
Czasopismo naukowe
Tytuł :
Patient-individual phenotypes of glioblastoma stem cells are conserved in culture and associate with radioresistance, brain infiltration and patient prognosis.
Autorzy :
Ganser K; Department of Radiation Oncology, University of Tübingen, Tübingen, Germany.
Eckert F; Department of Radiation Oncology, University of Tübingen, Tübingen, Germany.
Riedel A; Department of Radiation Oncology, University of Tübingen, Tübingen, Germany.
Stransky N; Department of Radiation Oncology, University of Tübingen, Tübingen, Germany.; Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany.
Paulsen F; Department of Radiation Oncology, University of Tübingen, Tübingen, Germany.
Noell S; Department of Neurosurgery, University of Tübingen, Tübingen, Germany.
Krueger M; Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center, University of Tübingen, Tübingen, Germany.
Schittenhelm J; Department of Neuropathology, University of Tübingen, Tübingen, Germany.
Beck-Wödl S; Institute of Medical Genetics und Applied Genomics, University of Tübingen, Tübingen, Germany.
Zips D; Department of Radiation Oncology, University of Tübingen, Tübingen, Germany.
Ruth P; Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany.
Huber SM; Department of Radiation Oncology, University of Tübingen, Tübingen, Germany.
Klumpp L; Department of Radiation Oncology, University of Tübingen, Tübingen, Germany.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2022 May 15; Vol. 150 (10), pp. 1722-1733. Date of Electronic Publication: 2022 Feb 14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Brain Neoplasms*/genetics
Brain Neoplasms*/metabolism
Brain Neoplasms*/radiotherapy
Glioblastoma*/genetics
Glioblastoma*/metabolism
Glioblastoma*/radiotherapy
Brain/metabolism ; Cell Line, Tumor ; Humans ; Neoplasm Recurrence, Local/pathology ; Neoplastic Stem Cells/metabolism ; Nerve Tissue Proteins/genetics ; Phenotype ; Prognosis ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; RNA-Binding Proteins/genetics
Czasopismo naukowe
Tytuł :
Quantitative study of the changes in brain white matter before and after radiotherapy by applying multi-sequence MR radiomics.
Autorzy :
Chen M; College of Radiology, Shandong First Medical University & Shandong Academy of Medical Sciences, 250117, Jinan, China.
Wang L; Department of Radiation Physics, Shandong First Medical University Affiliated Cancer Hospital, Shandong Cancer Hospital and Institute (Shandong Cancer Hospital), 250117, Jinan, China.
Gong G; Department of Radiation Physics, Shandong First Medical University Affiliated Cancer Hospital, Shandong Cancer Hospital and Institute (Shandong Cancer Hospital), 250117, Jinan, China.
Yin Y; Department of Radiation Physics, Shandong First Medical University Affiliated Cancer Hospital, Shandong Cancer Hospital and Institute (Shandong Cancer Hospital), 250117, Jinan, China. .
Wang P; College of Radiology, Shandong First Medical University & Shandong Academy of Medical Sciences, 250117, Jinan, China. .
Pokaż więcej
Źródło :
BMC medical imaging [BMC Med Imaging] 2022 May 13; Vol. 22 (1), pp. 86. Date of Electronic Publication: 2022 May 13.
Typ publikacji :
Journal Article
MeSH Terms :
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/radiotherapy
White Matter*/diagnostic imaging
Humans ; Magnetic Resonance Imaging/methods
Czasopismo naukowe
Tytuł :
Antitumor Activity of a Mitochondrial-Targeted HSP90 Inhibitor in Gliomas.
Autorzy :
Wei S; Department of Thoracic Surgery, Institute of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Neurosurgery, Duke University School of Medicine, Durham, North Carolina.
Yin D; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Neurosurgery, Duke University School of Medicine, Durham, North Carolina.; Department of Orthopedics, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Yu S; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Neurosurgery, Duke University School of Medicine, Durham, North Carolina.; Department of Oncology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Lin X; Department of Computer Science, Ying Wu College of Computing, New Jersey Institute of Technology, Newark, New Jersey.
Savani MR; Department of Neurosurgery, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas.
Du K; Department of Computer Science, Ying Wu College of Computing, New Jersey Institute of Technology, Newark, New Jersey.
Ku Y; Department of Thoracic Surgery, Institute of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Wu D; Department of Thoracic Surgery, Institute of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Li S; Department of Thoracic Surgery, Institute of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Liu H; Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Tian M; Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Neurosurgery Research Laboratory, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Chen Y; Department of Thoracic Surgery, Institute of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Bowie M; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Neurosurgery, Duke University School of Medicine, Durham, North Carolina.
Hariharan S; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Neurosurgery, Duke University School of Medicine, Durham, North Carolina.
Waitkus M; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Neurosurgery, Duke University School of Medicine, Durham, North Carolina.
Keir ST; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Neurosurgery, Duke University School of Medicine, Durham, North Carolina.
Sugarman ET; Philadelphia College of Osteopathic Medicine, Philadelphia, Pennsylvania.
Deek RA; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Labrie M; Knight Cancer Institute, Oregon Health Sciences University, Portland, Oregon.
Khasraw M; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Neurosurgery, Duke University School of Medicine, Durham, North Carolina.
Lu Y; Division of Cancer Medicine, Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Mills GB; Knight Cancer Institute, Oregon Health Sciences University, Portland, Oregon.
Herlyn M; The Wistar Institute, Philadelphia, Pennsylvania.
Wu K; Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Liu L; Department of Thoracic Surgery, Institute of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Wei Z; Department of Computer Science, Ying Wu College of Computing, New Jersey Institute of Technology, Newark, New Jersey.
Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
Abdullah K; Department of Neurosurgery, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas.
Zhang G; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Neurosurgery, Duke University School of Medicine, Durham, North Carolina.; Department of Pathology, Duke University School of Medicine, Durham, North Carolina.
Ashley DM; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Neurosurgery, Duke University School of Medicine, Durham, North Carolina.
Pokaż więcej
Źródło :
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 May 13; Vol. 28 (10), pp. 2180-2195.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents*/therapeutic use
Brain Neoplasms*/drug therapy
Brain Neoplasms*/genetics
Brain Neoplasms*/pathology
Glioma*/drug therapy
Glioma*/genetics
Glioma*/metabolism
Animals ; Cell Line, Tumor ; Humans ; Mice ; Mitochondria/metabolism ; Temozolomide/pharmacology ; Temozolomide/therapeutic use ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
Cyanidin-3-O-glucoside inhibits the β-catenin/MGMT pathway by upregulating miR-214-5p to reverse chemotherapy resistance in glioma cells.
Autorzy :
Zhou Y; College of Pharmacy, Hubei University of Chinese Medicine, No. 16 Huangjiahu West Road, Huangjiahu University Town, Hongshan District, Wuhan, 430065, Hubei, China.; Department of Pharmacy, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, Hubei, China.
Chen L; Department of Pharmacy, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, Hubei, China.
Ding D; Department of Pharmacy, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, Hubei, China.; Department of Infectious Diseases, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, Hubei, China.
Li Z; College of Pharmacy, Hubei University of Chinese Medicine, No. 16 Huangjiahu West Road, Huangjiahu University Town, Hongshan District, Wuhan, 430065, Hubei, China.
Cheng L; College of Pharmacy, Hubei University of Chinese Medicine, No. 16 Huangjiahu West Road, Huangjiahu University Town, Hongshan District, Wuhan, 430065, Hubei, China.
You Q; College of Pharmacy, Hubei University of Chinese Medicine, No. 16 Huangjiahu West Road, Huangjiahu University Town, Hongshan District, Wuhan, 430065, Hubei, China. .
Zhang S; College of Pharmacy, Hubei University of Chinese Medicine, No. 16 Huangjiahu West Road, Huangjiahu University Town, Hongshan District, Wuhan, 430065, Hubei, China. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2022 May 11; Vol. 12 (1), pp. 7773. Date of Electronic Publication: 2022 May 11.
Typ publikacji :
Journal Article
MeSH Terms :
Brain Neoplasms*/drug therapy
Brain Neoplasms*/genetics
Brain Neoplasms*/pathology
Glioma*/drug therapy
Glioma*/genetics
Glioma*/pathology
MicroRNAs*/metabolism
Anthocyanins ; Antineoplastic Agents, Alkylating/pharmacology ; Antineoplastic Agents, Alkylating/therapeutic use ; Apoptosis/genetics ; Cell Line, Tumor ; DNA Modification Methylases/genetics ; DNA Repair Enzymes ; Drug Resistance, Neoplasm/genetics ; Gene Expression Regulation, Neoplastic ; Glucosides/pharmacology ; Glucosides/therapeutic use ; Humans ; Temozolomide/pharmacology ; Temozolomide/therapeutic use ; Tumor Suppressor Proteins/genetics ; beta Catenin/genetics ; beta Catenin/metabolism
Czasopismo naukowe
Tytuł :
Liquid biopsies to occult brain metastasis.
Autorzy :
Rehman AU; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68108, USA.
Khan P; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68108, USA.
Maurya SK; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68108, USA.
Siddiqui JA; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68108, USA.; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, 68108, USA.
Santamaria-Barria JA; Department of Surgery, University of Nebraska Medical Center, Omaha, NE, 68108, USA.
Batra SK; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68108, USA.; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, 68108, USA.; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE-68198, USA.
Nasser MW; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68108, USA. .; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, 68108, USA. .
Pokaż więcej
Źródło :
Molecular cancer [Mol Cancer] 2022 May 10; Vol. 21 (1), pp. 113. Date of Electronic Publication: 2022 May 10.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Brain Neoplasms*/diagnosis
Brain Neoplasms*/genetics
Breast Neoplasms*/diagnosis
Breast Neoplasms*/genetics
Neoplastic Cells, Circulating*/pathology
Biomarkers, Tumor/genetics ; Female ; Humans ; Liquid Biopsy/methods ; Tumor Microenvironment
Czasopismo naukowe
Tytuł :
Brain-targeting biomimetic nanoparticles for codelivery of celastrol and LY2157299 for reversing glioma immunosuppression.
Autorzy :
Zhu S; Department of Pharmacology, Zhejiang University City College, 50 Huzhou Road, Hangzhou 310015, China; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; Department of pharmacy, Zhejiang University, Hangzhou, China.
Sun F; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Zhao P; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Liang G; Department of Pharmacology, Zhejiang University City College, 50 Huzhou Road, Hangzhou 310015, China; Department of pharmacy, Zhejiang University, Hangzhou, China.
Sun X; Department of Pharmacology, Zhejiang University City College, 50 Huzhou Road, Hangzhou 310015, China.
Zeng L; Department of Pharmacology, Zhejiang University City College, 50 Huzhou Road, Hangzhou 310015, China. Electronic address: .
Huang Y; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; Zhongshan Institute for Drug Discovery, SIMM, CAS, Zhongshan 528437, China; NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients, Shanghai 201203, China; Taizhou University, School of Advanced Study, Institute of Natural Medicine and Health Product, Taizhou 318000, China. Electronic address: .
Pokaż więcej
Źródło :
International journal of pharmaceutics [Int J Pharm] 2022 May 10; Vol. 619, pp. 121709. Date of Electronic Publication: 2022 Mar 29.
Typ publikacji :
Journal Article
MeSH Terms :
Brain Neoplasms*/drug therapy
Brain Neoplasms*/metabolism
Glioma*/drug therapy
Glioma*/metabolism
Nanoparticles*
Albumins/metabolism ; Animals ; Biomimetics ; Blood-Brain Barrier/metabolism ; Brain/metabolism ; Cell Line, Tumor ; Drug Delivery Systems ; Immunosuppression Therapy ; Mice ; Pentacyclic Triterpenes ; Pyrazoles ; Quinolines ; Transforming Growth Factor beta1/metabolism
Czasopismo naukowe
Tytuł :
Cellular Telephone Use and the Risk of Brain Tumors: Update of the UK Million Women Study.
Autorzy :
Schüz J; International Agency for Research on Cancer (IARC/WHO), Environment and Lifestyle Epidemiology Branch, Lyon, France.
Pirie K; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Reeves GK; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Floud S; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Beral V; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Pokaż więcej
Corporate Authors :
Million Women Study Collaborators
Źródło :
Journal of the National Cancer Institute [J Natl Cancer Inst] 2022 May 09; Vol. 114 (5), pp. 704-711.
Typ publikacji :
Journal Article
MeSH Terms :
Brain Neoplasms*/epidemiology
Brain Neoplasms*/etiology
Cell Phone*
Glioma*
Meningeal Neoplasms*
Aged, 80 and over ; Female ; Humans ; Male ; Prospective Studies ; Risk Factors ; Telephone ; United Kingdom/epidemiology
Czasopismo naukowe
Tytuł :
Diagnostic radiological examinations and risk of intracranial tumours in adults-findings from the Interphone Study.
Autorzy :
Auvinen A; Faculty of Social Sciences, Unit of Health Sciences, Tampere University, Tampere, Finland.; STUK-Radiation and Nuclear Safety Authority, Helsinki, Finland.
Cardis E; Barcelona Institute of Global Health (ISGlobal), Centre for Research in Environmental Epidemiology, Universitat Pompeu Funebra, Barcelona, Spain.; CIBER Epidemiologia y Salud Publica, Madrid, Spain.
Blettner M; University of Mainz, IMBEI, Mainz, Germany.
Moissonnier M; International Agency for Research on Cancer, Lyon, France.
Sadetzki S; Gertner Institute, Tel Aviv, Israel.
Giles G; Cancer Council Victoria, Melbourne, VIC, Australia.
Johansen C; Danish Cancer Society Research Center, Copenhagen, Denmark.
Swerdlow A; Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK.; Division of Breast Cancer Research, Institute of Cancer Research, London, UK.
Cook A; School of Population and Global Health, University of Western Australia, Crawley, WA, Australia.
Fleming S; University of Leeds, Leeds, UK.
Berg-Beckhoff G; Faculty of Public Health, University of Bielefeld, Germany.
Iavarone I; Istituto Superiore di Sanità, Rome, Italy.
Parent ME; INRS Centre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique, Université du Québec, Laval, QC, Canada.
Woodward A; School of Population Health, University of Auckland, Auckland, New Zealand.
Tynes T; National Institute of Occupational Health, Oslo, Norway.
McBride M; British Columbia Cancer Agency, Vancouver, BC, Canada.
Krewski D; McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, ON, Canada.
Feychting M; Karolinska Institutet, Stockholm, Sweden.
Takebayashi T; Keio University School of Medicine, Tokyo, Japan.
Armstrong B; School of Public Health, University of Sydney, Sydney, NSW, Australia.
Hours M; Université Lyon 1, IFSTTAR, UMRESTTE, Bron, France.
Siemiatycki J; University of Montreal, Montreal, QC, Canada.
Lagorio S; Istituto Superiore di Sanità, Rome, Italy.
Larsen SB; Danish Cancer Society Research Center, Copenhagen, Denmark.
Schoemaker M; Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK.
Klaeboe L; Norwegian Radiation Protection Authority, Østerås, Norway.
Lönn S; Karolinska Institutet, Stockholm, Sweden.; Region Halland, Research and Development, Sweden.
Schüz J; International Agency for Research on Cancer, Lyon, France.
Pokaż więcej
Corporate Authors :
and the INTERPHONE study group
Źródło :
International journal of epidemiology [Int J Epidemiol] 2022 May 09; Vol. 51 (2), pp. 537-546.
Typ publikacji :
Journal Article
MeSH Terms :
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/epidemiology
Brain Neoplasms*/etiology
Cell Phone*
Glioma*/complications
Glioma*/diagnostic imaging
Glioma*/epidemiology
Meningeal Neoplasms*/complications
Meningeal Neoplasms*/diagnostic imaging
Meningeal Neoplasms*/epidemiology
Meningioma*/complications
Meningioma*/diagnostic imaging
Meningioma*/epidemiology
Neuroma, Acoustic*/complications
Neuroma, Acoustic*/diagnostic imaging
Neuroma, Acoustic*/epidemiology
Adult ; Case-Control Studies ; Humans ; Isotopes ; Risk Factors
Czasopismo naukowe
Tytuł :
Effects of Long-Term Temozolomide Treatment on Glioblastoma and Astrocytoma WHO Grade 4 Stem-like Cells.
Autorzy :
Feldheim J; Section Experimental Neurosurgery, Department of Neurosurgery, University of Würzburg, D-97080 Würzburg, Germany.; Division of Clinical Neurooncology, Department of Neurology, University Hospital Essen, D-45131 Essen, Germany.; Center for Translational Neuro- and Behavioral Sciences, University Hospital Essen, D-45131 Essen, Germany.
Kessler AF; Section Experimental Neurosurgery, Department of Neurosurgery, University of Würzburg, D-97080 Würzburg, Germany.
Feldheim JJ; Section Experimental Neurosurgery, Department of Neurosurgery, University of Würzburg, D-97080 Würzburg, Germany.; Department of Neurosurgery, University Hospital Essen, D-45131 Essen, Germany.
Schulz E; Section Experimental Neurosurgery, Department of Neurosurgery, University of Würzburg, D-97080 Würzburg, Germany.
Wend D; Section Experimental Neurosurgery, Department of Neurosurgery, University of Würzburg, D-97080 Würzburg, Germany.
Lazaridis L; Division of Clinical Neurooncology, Department of Neurology, University Hospital Essen, D-45131 Essen, Germany.; Center for Translational Neuro- and Behavioral Sciences, University Hospital Essen, D-45131 Essen, Germany.
Kleinschnitz C; Division of Clinical Neurooncology, Department of Neurology, University Hospital Essen, D-45131 Essen, Germany.; Center for Translational Neuro- and Behavioral Sciences, University Hospital Essen, D-45131 Essen, Germany.
Glas M; Division of Clinical Neurooncology, Department of Neurology, University Hospital Essen, D-45131 Essen, Germany.; Center for Translational Neuro- and Behavioral Sciences, University Hospital Essen, D-45131 Essen, Germany.
Ernestus RI; Section Experimental Neurosurgery, Department of Neurosurgery, University of Würzburg, D-97080 Würzburg, Germany.
Brandner S; Division of Neuropathology, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College Hospitals NHS Foundation Trust, London WC1N3BG, UK.
Monoranu CM; Department of Neuropathology, Institute of Pathology, University of Würzburg, D-97080 Würzburg, Germany.
Löhr M; Section Experimental Neurosurgery, Department of Neurosurgery, University of Würzburg, D-97080 Würzburg, Germany.
Hagemann C; Section Experimental Neurosurgery, Department of Neurosurgery, University of Würzburg, D-97080 Würzburg, Germany.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2022 May 07; Vol. 23 (9). Date of Electronic Publication: 2022 May 07.
Typ publikacji :
Journal Article
MeSH Terms :
Astrocytoma*/drug therapy
Astrocytoma*/genetics
Brain Neoplasms*/drug therapy
Brain Neoplasms*/genetics
Brain Neoplasms*/pathology
Glioblastoma*/drug therapy
Glioblastoma*/genetics
Glioblastoma*/pathology
Antineoplastic Agents, Alkylating/pharmacology ; Antineoplastic Agents, Alkylating/therapeutic use ; DNA Methylation ; DNA Modification Methylases/genetics ; DNA Modification Methylases/metabolism ; DNA Repair Enzymes/genetics ; DNA Repair Enzymes/metabolism ; Humans ; Isocitrate Dehydrogenase/genetics ; Neoplasm Recurrence, Local/genetics ; Temozolomide/therapeutic use ; World Health Organization
Czasopismo naukowe
Tytuł :
Integrated proteomic analysis of low-grade gliomas reveals contributions of 1p-19q co-deletion to oligodendroglioma.
Autorzy :
Wong D; Pathology and Laboratory Medicine, Vancouver General Hospital, University of British Columbia, Vancouver, Canada.; Molecular Oncology, BC Cancer Agency, Vancouver, Canada.
Lee TH; Molecular Oncology, BC Cancer Agency, Vancouver, Canada.
Lum A; Molecular Oncology, BC Cancer Agency, Vancouver, Canada.
Tao VL; Pathology and Laboratory Medicine, Vancouver General Hospital, University of British Columbia, Vancouver, Canada.
Yip S; Pathology and Laboratory Medicine, Vancouver General Hospital, University of British Columbia, Vancouver, Canada. .; Molecular Oncology, BC Cancer Agency, Vancouver, Canada. .
Pokaż więcej
Źródło :
Acta neuropathologica communications [Acta Neuropathol Commun] 2022 May 07; Vol. 10 (1), pp. 70. Date of Electronic Publication: 2022 May 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Brain Neoplasms*/genetics
Brain Neoplasms*/pathology
Glioma*/genetics
Glioma*/pathology
Oligodendroglioma*/genetics
Oligodendroglioma*/pathology
Adult ; Chromosomes, Human, Pair 1/genetics ; Humans ; Isocitrate Dehydrogenase/genetics ; Mutation/genetics ; Proteomics
Czasopismo naukowe
Tytuł :
Application of piecewise VMAT technique to whole-brain radiotherapy with simultaneous integrated boost for multiple metastases.
Autorzy :
Xu Y; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Xu Y; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Men K; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Xiao J; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Dai J; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. .
Pokaż więcej
Źródło :
Radiation oncology (London, England) [Radiat Oncol] 2022 May 07; Vol. 17 (1), pp. 86. Date of Electronic Publication: 2022 May 07.
Typ publikacji :
Journal Article
MeSH Terms :
Brain Neoplasms*/radiotherapy
Brain Neoplasms*/secondary
Radiotherapy, Intensity-Modulated*/methods
Arthrogryposis ; Cholestasis ; Cranial Irradiation/methods ; Female ; Hippocampus ; Humans ; Male ; Organs at Risk ; Radiotherapy Dosage ; Radiotherapy Planning, Computer-Assisted/methods ; Renal Insufficiency ; Retrospective Studies
SCR Disease Name :
Arthrogryposis renal dysfunction cholestasis syndrome
Czasopismo naukowe
Tytuł :
The RNA-binding protein fragile-X mental retardation autosomal 1 (FXR1) modulates glioma cells sensitivity to temozolomide by regulating ferroptosis.
Autorzy :
Wei Y; Department of Neurosurgery, Ningbo No.1 Hospital, Ningbo, Zhejiang Province, China.
Duan S; Department of Rehabilitation, Ningbo Zhenhai Longsai Hospital, Ningbo, Zhejiang Province, China.
Gong F; Department of Neurosurgery, Ningbo No.1 Hospital, Ningbo, Zhejiang Province, China.
Li Q; Department of Neurosurgery, Hwa Mei Hospital, University of Chinese Academy of Sciences (Ningbo No.2 Hospital), Ningbo, Zhejiang Province, China. Electronic address: .
Pokaż więcej
Źródło :
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2022 May 07; Vol. 603, pp. 153-159. Date of Electronic Publication: 2022 Feb 26.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Brain Neoplasms*/drug therapy
Brain Neoplasms*/genetics
Brain Neoplasms*/metabolism
Ferroptosis*
Glioma*/drug therapy
Glioma*/genetics
Glioma*/metabolism
Intellectual Disability*
Antineoplastic Agents, Alkylating/pharmacology ; Antineoplastic Agents, Alkylating/therapeutic use ; Apoptosis ; Cell Line, Tumor ; Cell Proliferation ; Drug Resistance, Neoplasm/genetics ; Humans ; RNA/pharmacology ; RNA-Binding Proteins/metabolism ; Temozolomide/pharmacology ; Temozolomide/therapeutic use
Czasopismo naukowe
Tytuł :
Boron neutron capture therapy and add-on bevacizumab in patients with recurrent malignant glioma.
Autorzy :
Furuse M; Department of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka 569-8686, Japan.
Kawabata S; Department of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka 569-8686, Japan.
Wanibuchi M; Department of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka 569-8686, Japan.; Kansai BNCT Medical Center, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka 569-8686, Japan.
Shiba H; Department of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka 569-8686, Japan.
Takeuchi K; Department of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka 569-8686, Japan.; Cerebrospinal center, Shiroyama Hospital, Habikino, Osaka 583-0872, Japan.
Kondo N; Institute for Integrated Radiation and Nuclear Science, Kyoto University, Kumatori, Osaka 590-0494, Japan.
Tanaka H; Institute for Integrated Radiation and Nuclear Science, Kyoto University, Kumatori, Osaka 590-0494, Japan.
Sakurai Y; Institute for Integrated Radiation and Nuclear Science, Kyoto University, Kumatori, Osaka 590-0494, Japan.
Suzuki M; Cerebrospinal center, Shiroyama Hospital, Habikino, Osaka 583-0872, Japan.
Ono K; Kansai BNCT Medical Center, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka 569-8686, Japan.
Miyatake SI; Department of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka 569-8686, Japan.; Kansai BNCT Medical Center, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka 569-8686, Japan.
Pokaż więcej
Źródło :
Japanese journal of clinical oncology [Jpn J Clin Oncol] 2022 May 05; Vol. 52 (5), pp. 433-440.
Typ publikacji :
Journal Article
MeSH Terms :
Boron Neutron Capture Therapy*/adverse effects
Brain Neoplasms*/drug therapy
Brain Neoplasms*/radiotherapy
Glioblastoma*/drug therapy
Glioblastoma*/radiotherapy
Glioma*/drug therapy
Glioma*/radiotherapy
Radiation Injuries*/etiology
Bevacizumab/therapeutic use ; Humans ; Necrosis/etiology ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/radiotherapy
Czasopismo naukowe
Tytuł :
Cancer cell heterogeneity and plasticity: A paradigm shift in glioblastoma.
Autorzy :
Yabo YA; NORLUX Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg, Luxembourg.; Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.
Niclou SP; NORLUX Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg, Luxembourg.; Department of Biomedicine, University of Bergen, Bergen, Norway.
Golebiewska A; Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.
Pokaż więcej
Źródło :
Neuro-oncology [Neuro Oncol] 2022 May 04; Vol. 24 (5), pp. 669-682.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Brain Neoplasms*/genetics
Brain Neoplasms*/pathology
Glioblastoma*/genetics
Glioblastoma*/pathology
Ecosystem ; Humans ; Neoplastic Stem Cells/pathology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies